The Neurovascular Coiling Assist Device (NCAD) market is a subset of the larger Neurology Devices market. NCADs are used to treat aneurysms, which are bulges in the walls of blood vessels caused by weakened vessel walls. NCADs are designed to help physicians coil the aneurysm, which is a minimally invasive procedure that helps reduce the risk of rupture. NCADs are typically composed of a delivery system, a guidewire, and a microcatheter. The delivery system is used to guide the guidewire and microcatheter to the aneurysm, while the guidewire and microcatheter are used to deliver the coils to the aneurysm. NCADs are used in a variety of medical settings, including hospitals, clinics, and ambulatory surgery centers. The NCAD market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the NCAD market include Medtronic, Stryker, Johnson & Johnson, and Boston Scientific. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
